NOX‐A12 has been shown to decrease tumour metastasis and drug resistance caused by cancer cell homing.31 A CD38‐specific ssDNA aptamer drug conjugate (ApDC) targets drug delivery to CD38‐expressing MM cells and releases the drug payload intracellularly.18 However, the use of this ApDC to target c‐met in MM has yet to be reported. This evidence concerns the gene MET and Miyoshi myopathy.